Printed from Voxsanity (voxsanity.com.au) — NCT07063797 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Type 2 Diabetes Trial, Not Yet Recruiting
NCT07063797
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A person must have a confirmed diagnosis of type 2 diabetes, based on China's 2024 diabetes guidelines.
- Men must be aged 50 or older; women must be aged 45 or older and have been through menopause for more than 2 years.
- A person must have had diabetes for more than 10 years, or have at least one of the following: diabetic eye disease; a certain level of protein in the urine suggesting kidney strain; reduced kidney filtering function; coronary heart disease; a history of stroke caused by blocked blood flow; a history of a brief stroke-like episode (TIA); or significant narrowing (50% or more) of arteries in the neck, brain, or legs.
- A blood sugar control measure called HbA1c must be 8.0% or below, tested within the past month.
- A person must have a history of a hip or spinal fracture caused by low bone strength, or a fracture at another site (not the skull, feet, or hands) combined with a bone density score below a certain threshold, or a bone density score that is significantly low even without a prior fracture (confirm with trial site for exact score thresholds).
- When bone density is measured at the lower spine (L1–L4), at least two of those spinal sections must produce results that can be properly assessed.
- A person must be willing to participate and must sign a consent form agreeing to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a medical condition that causes bone loss as a secondary effect, such as certain metabolic bone diseases, Cushing's syndrome, high prolactin levels, or similar conditions.
- People who have had a malignant (cancerous) tumour in the past 5 years, unless it is one considered likely to be fully cured, such as certain fully removed skin cancers, cervical cancer, or a type of early breast cancer.
- People who have received intravenous bisphosphonate bone medications in the past 2 years, or oral bisphosphonate medications in the past year.
- People who have a history of, or currently have, bone infection in the jaw or jaw bone tissue damage, unhealed wounds in the mouth from dental surgery, active dental or jaw problems needing surgery, or who are expected to need invasive dental procedures during the trial.
- People who have received the bone medications denosumab, teriparatide, or romosozumab in the past 6 months.
- People who have used calcitonin continuously for more than 3 months within the past year.
- People who have used steroid medications (at a dose equivalent to more than 5 mg per day of prednisone) for more than 10 days within the past 6 weeks.
- People with a vitamin D level (measured as 25-hydroxyvitamin D) below 10 ng/mL.
- People who have an active infection currently requiring treatment throughout the body (systemic treatment).
- People with serious uncontrolled health conditions, including advanced heart failure, severe irregular heart rhythms, severe liver problems, or severely reduced kidney function (confirm with trial site for exact thresholds).
- People with abnormally low blood calcium, abnormally high blood calcium, or too much calcium being passed in the urine.
- People who have a known allergy to the study drug.
- People who are currently taking part in another clinical drug trial.
- People whom the trial doctor considers unsuitable for the study for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Phone: 13501002126
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
31 July 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
change rate of lumbar bone density
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.